Trial shows fewer HF hospitalizations in HFpEF ...

A trial testing the aldosterone blocker spironolactone in patients with heart failure with preserved ejection fraction (HFpEF ...

AB-1002 is an investigational one-time gene therapy administered directly to the heart to promote production of a modified version (I-1c) of the naturally occurring protein inhibitor-1, designed to ...

A research team from Cincinnati's Christ Hospital found that AI improved care and reduced hospitalizations for heart failure ...

An artificial intelligence (AI) virtual assistant designed to help patients suffering from heart failure with reduced ejection fraction ...

HRS-1893 (also known as BHB-1893) is a selective, small-molecule, cardiac myosin inhibitor engineered to improve heart performance in patients with HCM. By modulating cardiac contractility, HRS-1893 ...

An increasing proportion of patients with heart failure receive a combination of four medications shown to improve prognosis ...

Treatment management guided by the use of a noninvasive device to monitor fluid accumulation in the lungs substantially reduced hospitalizations and deaths among patients with heart failure with ...

Bayer BAYRY’s wholly owned subsidiary, AskBio Inc., announced the completion of patient enrollment in the mid-stage GenePHIT ...

Background The Heart Failure Association Pre-test Assessment, Echocardiography and Natriuretic Peptide, Functional testing, ...

In a population of patients with HF and low ejection, those aged at least 63 years had significantly reduced verbal memory compared with younger patients, new study results indicated. The ...

Is your heart functioning properly? There is a test which can measure this, which is often recommended by medical ...